Browse studies

Find your next paid study

4 recruiting studies matching your filters

A Clinical Trial to Evaluate the Effects of the NeuEve Dryness Treatment Kit on Vaginal Health, Comfort, and Quality of Life in Postmenopausal Women

This is a decentralized, single-group, open-label clinical trial evaluating a 12-week regimen of the NeuEve Dryness Treatment Kit (comprising Feminine Moisture…

Relieves Vaginal Dryness / Improves Self-LubricationImproves Strength & Elasticity of Vagina (Aka Collagen and Elastin)Improves Vaginal Wall Thickness+7 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

NeuEveNCT07893795

Observational

Radicle Women's Sexual HealthTM CIX: A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Sexual Health and Related Health Outcomes

Radicle Women's Sexual Health™ CIX: A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness product…

Sexual Desire

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Radicle ScienceNCT07835763

Phase 2

An Open-Label Pilot Study of the Pharmacokinetics and Safety of 50 Mg Oral Testosterone Undecanoate (Kyzatrex) in Menopausal Women with Low Testosterone and Hypoactive Sexual Desire Disorder

This is an unblinded study to be conducted at a single research center, San Diego Sexual Medicine. Eligible subjects will receive 50 mg capsules of Kyzatrax® t…

Hypoactive Sexual Desire Disorder

Estimated

~$75 – $3,000

Actual pay is set by the research site.

San Diego Sexual MedicineNCT06082817

Phase 1

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

This study is open to women who have early-stage breast cancer and are on aromatase inhibitor (AI) therapy, and who have hypoactive sexual desire disorder (HSD…

Early-stage Breast CancerHypoactive Sexual Desire DisorderHormone Receptor Positive Breast Carcinoma+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Illinois at ChicagoNCT07596212